Skip to content

Neural Structure and Function in Tourette Syndrome: distinguishing neural structure and function in Tourette Syndrome from attention-deficit/hyperactivity disorder.

Neural Structure and Function in Tourette Syndrome: distinguishing neural structure and function in Tourette Syndrome from attention-deficit/hyperactivity disorder. - Neural Structure and Function in TS and ADHD

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON41025
Enrollment
60
Registered
2014-07-03
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ontwikkelingsstoornissen NEG Tourette's and ADHD

Interventions

None listed

Sponsors

Donders Institute of Brain, Cognition and Behavior
Lead Sponsor

Eligibility

Age
2 Years to 11 Years

Inclusion criteria

Inclusion criteria: (1) Aged 8 - 12 years at initial inclusion (2) IQ > 70 (3) Ability to speak and comprehend the native language of the country in which the assessment takes place (4) Caucasian descent (5) Signed informed consent by parents or legal representative (6) DSM-5 diagnosis of Tourette's Disorder or Persistent (chronic) Motor or Vocal tic Disorder (motor tics only) (APA, 2013).

Exclusion criteria

Exclusion criteria: (1) Intellectual disability (IQ

Design outcomes

Primary

MeasureTime frame
Structural, diffusion and functional (resting state and task specific) MRI images will be obtained (approx. 60mins). Two neuropsychological tasks will be performed in an fMRI environment (go/no-go and monetary reward anticipation) with another 4 tasks completed outside of the MRI environment (motor inhibition and cognitive flexibility, verbal working memory, motor speed, cognitive flexibility). Phenotyping will be done by semi-structured interview for the Yale Global Tic Severity Scale (YGTSS) and Children*s Yale-Brown Obsessive Compulsive Scale (CY-BOCS). ADHD symptoms will be assessed additionally by Conners questionnaire.

Secondary

MeasureTime frame
Secundary endpoints are (1) genotypes of candidate genes and (2) lab assesments of various proteins in blood plasma.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)